Study of Roxadustat's Effect on Anemia in Patients With Diabetic Kidney Disease

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 124 participants.

Also called NCT07359027

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 124 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT07359027
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT07359027. Allocation not applicable; no masking; primary purpose treatment. Start 2021-11-02 (actual); primary completion 2022-12-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study of Roxadustat's Effect on Anemia in Patients With Diabetic Kidney Disease
Condition
Diabetic Kidney Disease
Condition
Anemia
Intervention (Drug)
Roxadustat
Lead sponsor
Second Xiangya Hospital of Central South University (class: other)
Collaborator
Xiangya Hospital of Central South University (class: other)
Collaborator
The Third Xiangya Hospital of Central South University (class: other)

Record details

Record id
cardio:ct-nct07359027
Content hash
624b1be1e6e13e7d1d862dc6dee5e00d8d70966abb64448d15191c217898579e